212 related articles for article (PubMed ID: 17044568)
1. Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
Fadul CE; Kominsky AL; Meyer LP; Kingman LS; Kinlaw WB; Rhodes CH; Eskey CJ; Simmons NE
J Neurosurg; 2006 Oct; 105(4):621-6. PubMed ID: 17044568
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response.
Strowd RE; Salvatori R; Laterra JJ
J Oncol Pharm Pract; 2016 Jun; 22(3):517-22. PubMed ID: 25616657
[TBL] [Abstract][Full Text] [Related]
3. Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
Bilbao I; Egaña N; García C; Olaizola I
Endocrinol Diabetes Nutr; 2017 Dec; 64(10):564-566. PubMed ID: 29137963
[No Abstract] [Full Text] [Related]
4. Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment.
Philippon M; Morange I; Barrie M; Barlier A; Taieb D; Dufour H; Conte-Devolx B; Brue T; Castinetti F
Ann Endocrinol (Paris); 2012 Jun; 73(3):225-9. PubMed ID: 22520146
[TBL] [Abstract][Full Text] [Related]
5. Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature.
Lizzul L; Lombardi G; Barbot M; Ceccato F; Gardiman MP; Regazzo D; Bellu L; Mazza E; Losa M; Scaroni C
Pituitary; 2020 Aug; 23(4):359-366. PubMed ID: 32232709
[TBL] [Abstract][Full Text] [Related]
6. Evolution of a prolactin-secreting pituitary microadenoma into a fatal carcinoma: a case report.
Guastamacchia E; Triggiani V; Tafaro E; De Tommasi A; De Tommasi C; Luzzi S; Sabbà C; Resta F; Terreni MR; Losa M
Minerva Endocrinol; 2007 Sep; 32(3):231-6. PubMed ID: 17912159
[TBL] [Abstract][Full Text] [Related]
7. Gangliocytoma masquerading as a prolactinoma. Case report.
McCowen KC; Glickman JN; Black PM; Zervas NT; Lidov HG; Garber JR
J Neurosurg; 1999 Sep; 91(3):490-5. PubMed ID: 10470826
[TBL] [Abstract][Full Text] [Related]
8. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?
Phillips J; East HE; French SE; Melcescu E; Hamilton RD; Nicholas WC; Fratkin JF; Parent AD; Luzardo G; Koch CA
Hormones (Athens); 2012; 11(4):477-82. PubMed ID: 23422771
[TBL] [Abstract][Full Text] [Related]
9. Case report of sarcoma of the sella caused by postoperative radiotherapy for a prolactin-producing pituitary adenoma.
Kurosaki M; Kambe A; Ishibashi M; Watanabe T; Horie Y
Brain Tumor Pathol; 2014 Jul; 31(3):187-91. PubMed ID: 24446079
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas.
Lasolle H; Cortet C; Castinetti F; Cloix L; Caron P; Delemer B; Desailloud R; Jublanc C; Lebrun-Frenay C; Sadoul JL; Taillandier L; Batisse-Lignier M; Bonnet F; Bourcigaux N; Bresson D; Chabre O; Chanson P; Garcia C; Haissaguerre M; Reznik Y; Borot S; Villa C; Vasiljevic A; Gaillard S; Jouanneau E; Assié G; Raverot G
Eur J Endocrinol; 2017 Jun; 176(6):769-777. PubMed ID: 28432119
[TBL] [Abstract][Full Text] [Related]
11. Use of temozolomide in aggressive pituitary tumors: case report.
Mohammed S; Kovacs K; Mason W; Smyth H; Cusimano MD
Neurosurgery; 2009 Apr; 64(4):E773-4; discussion E774. PubMed ID: 19349807
[TBL] [Abstract][Full Text] [Related]
12. Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review.
Dai C; Sun B; Guan S; Wang W; Liu H; Li Y; Zhang J; Kang J
BMC Endocr Disord; 2021 Oct; 21(1):217. PubMed ID: 34715828
[TBL] [Abstract][Full Text] [Related]
13. Early Recognition and Initiation of Temozolomide Chemotherapy for Refractory, Invasive Pituitary Macroprolactinoma with Long-Term Sustained Remission.
Barkhoudarian G; Palejwala SK; Ogunbameru R; Wei H; Eisenberg A; Kelly DF
World Neurosurg; 2018 Oct; 118():118-124. PubMed ID: 30031177
[TBL] [Abstract][Full Text] [Related]
14. Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases.
Losa M; Mazza E; Terreni MR; McCormack A; Gill AJ; Motta M; Cangi MG; Talarico A; Mortini P; Reni M
Eur J Endocrinol; 2010 Dec; 163(6):843-51. PubMed ID: 20870708
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of total removal or subtotal removal combined gamma knife radiation on giant pituitary adenoma: a report of 160 cases].
Xiao QH; Huang SQ; Mao BY; Li GP; Ju Y
Ai Zheng; 2007 Jul; 26(7):742-7. PubMed ID: 17626751
[TBL] [Abstract][Full Text] [Related]
16. Pituitary atypical adenoma or carcinoma sensitive to temozolomide combined with radiation therapy: a case report of early identification and management.
Zhong C; Yin S; Zhou P; Jiang S
Turk Neurosurg; 2014; 24(6):963-6. PubMed ID: 25448217
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of leptomeningeally metastasised pituitary carcinoma with temozolomide.
van der Vlist A; Snijders TJ; Stades AME; Spliet WGM; De Vos FYFL
Neth J Med; 2017 Dec; 75(10):451-454. PubMed ID: 29256415
[TBL] [Abstract][Full Text] [Related]
18. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
[TBL] [Abstract][Full Text] [Related]
19. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiation therapy for pituitary adenoma.
Isobe K; Ohta M; Yasuda' S; Uno T; Hara R; Machida N; Saeki N; Yamaura A; Shigematsu N; Ito H
J Neurooncol; 2000 Jun; 48(2):135-40. PubMed ID: 11083077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
